Literature DB >> 1694661

Modulation by interferons of the expression of monocyte complement genes.

D F Lappin1, G D Birnie, K Whaley.   

Abstract

Interferons-alpha, -beta and -gamma (IFNs-alpha, -beta and -gamma) stimulated the synthesis of the second complement component (C2), Factor B (B) and C1 inhibitor (C1-inh) by human monocytes in vitro. The degree of increase of the secretion rates of C2, B and C1-inh was dose-dependent and proportional to increases in the abundances of their respective mRNAs. IFN-gamma was the most effective at stimulating monocyte C1-inh synthesis, whereas IFN-alpha and IFN-beta were marginally more effective at stimulating monocyte C2 and B synthesis. Kinetic studies showed that the effect of the IFNs was rapid, with maximum stimulation occurring within 1-2 h for all three proteins. After the removal of IFNs from cultures the C1-inh mRNA abundance remained elevated for over 24 h in IFN-gamma-treated monocytes but returned to control levels within 8 h in IFN-alpha-treated and IFN-beta-treated monocytes. The abundances of C2 mRNA and B mRNA also returned to basal values within 8 h after removal of any of the three cytokines from the cultures. Both IFN-alpha and IFN-beta acted synergistically with IFN-gamma to stimulate synthesis of C1-inh and B. This synergistic effect only occurred when the cytokines were present in the cultures simultaneously. The effects of IFN-gamma plus IFN-alpha or IFN-beta on C2 synthesis appeared to be additive rather than synergistic. IFN-gamma inhibited synthesis of C3 by monocytes, but IFN-alpha and IFN-beta had no effect on the synthesis of this protein. Furthermore, none of the three cytokines had any effect on the expression of actin mRNA in monocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694661      PMCID: PMC1131444          DOI: 10.1042/bj2680387

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  Differential mRNA responses in human macrophages activated by interferon-gamma and muramyl dipeptide.

Authors:  M W Vermeulen; J R David; H G Remold
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

2.  The role of ion channels and protein kinase C activation in the stimulation of complement protein synthesis.

Authors:  D Lappin; K Whaley
Journal:  J Clin Lab Immunol       Date:  1987-10

3.  Complement-subcomponent-C1-inhibitor synthesis by human monocytes.

Authors:  A C Yeung Laiwah; L Jones; A O Hamilton; K Whaley
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

4.  Selective inhibition of 28S ribosomal RNA in macrophages activated by interferon-gamma or -beta.

Authors:  L Varesio; M Clayton; D Radzioch; E Bonvini
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

5.  Down regulation of human monocyte differentiation antigens by interferon gamma.

Authors:  G S Firestein; N J Zvaifler
Journal:  Cell Immunol       Date:  1987-02       Impact factor: 4.868

6.  gamma-Interferon increases expression of class III complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes.

Authors:  R C Strunk; F S Cole; D H Perlmutter; H R Colten
Journal:  J Biol Chem       Date:  1985-12-05       Impact factor: 5.157

7.  Increased biosynthesis of complement components by cultured monocytes, synovial fluid macrophages and skynovial membrane cells from patients with rheumatoid arthritis.

Authors:  C de Ceulaer; S Papazoglou; K Whaley
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

8.  Gamma-interferon modulates human monocyte/macrophage transferrin receptor expression.

Authors:  R Taetle; J M Honeysett
Journal:  Blood       Date:  1988-06       Impact factor: 22.113

9.  Internal homologies of the Ba fragment from human complement component Factor B, a class III MHC antigen.

Authors:  B J Morley; R D Campbell
Journal:  EMBO J       Date:  1984-01       Impact factor: 11.598

10.  Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes.

Authors:  K Whaley
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Interferons 1992. How much of the promise has been realised?

Authors:  M A Volz; C H Kirkpatrick
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

2.  Synthesis and regulation of the fourth component of complement (C4) in the human monocytic cell line U937: comparison with that of the third component of complement (C3).

Authors:  H Tsukamoto; K Nagasawa; S Yoshizawa; Y Tada; A Ueda; Y Ueda; Y Niho
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

3.  Regulation of early complement components C3 and C4 in the synovium.

Authors:  T Collins; J A Winkelstein; K E Sullivan
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

4.  Synthesis of classical pathway complement components by chondrocytes.

Authors:  K Bradley; J North; D Saunders; W Schwaeble; M Jeziorska; D E Woolley; K Whaley
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

Review 5.  Complement biosynthesis by mononuclear phagocytes.

Authors:  A R McPhaden; K Whaley
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

6.  Interferon-induced transcriptional and post-transcriptional modulation of factor H and C4 binding-protein synthesis in human monocytes.

Authors:  D F Lappin; K Whaley
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

7.  Effect of interferon-gamma on complement gene expression in different cell types.

Authors:  D F Lappin; D Guc; A Hill; T McShane; K Whaley
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

8.  C3 synthesis by A549 alveolar epithelial cells is increased by interferon-gamma and dexamethasone.

Authors:  L D Hill; L Sun; M P Leuschen; T L Zach
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

9.  Expression of the components and regulatory proteins of the classical pathway of complement in normal and diseased synovium.

Authors:  P Gulati; D Guc; C Lemercier; D Lappin; K Whaley
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

10.  Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium.

Authors:  D Guc; P Gulati; C Lemercier; D Lappin; G D Birnie; K Whaley
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.